NCT00305201View on ClinicalTrials.gov

Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2007

Conditions

Kawasaki Disease

Interventions

DRUG

pravastatin

Trial Locations (1)

Unknown

Pontificia Universidad Catolica de Chile, School of Medicine, Santiago

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Pontificia Universidad Catolica de Chile

OTHER